| 臺大學術典藏 |
2020-05-25T06:52:10Z |
Phase II study of combination doxorubicin, interferon-�\, and high-dose tamoxifen treatment for advanced hepatocellular carcinoma
|
Cheng A.-L.;Wu C.-Y;Hsu C.-H;Yang C.-H;Yeh K.-H;Kuo S.-H;Li C.-C;Hsu C;Yen-Shen Lu; YEN-SHEN LU; Hsu C; Li C.-C; Kuo S.-H; Yeh K.-H; Yang C.-H; Hsu C.-H; Wu C.-Y; Cheng A.-L. |
| 臺大學術典藏 |
2020-05-25T06:52:09Z |
Phase II study of weekly paclitaxel and 24-hour infusion of high-dose 5-fluorouracil and leucovorin in the treatment of recurrent or metastatic gastric cancer
|
Yeh K.-H;Yen-Shen Lu;Hsu C.-H;Lin J.-F;Hsu C;Kuo S.-H;Li Jr. S;Cheng A.-L.; Yeh K.-H; YEN-SHEN LU; Hsu C.-H; Lin J.-F; Hsu C; Kuo S.-H; Li Jr. S; Cheng A.-L. |
| 臺大學術典藏 |
2020-05-25T06:52:08Z |
Effects of glucocorticoids on the growth and chemosensitivity of carcinoma cells are heterogeneous and require high concentration of functional glucocorticoid receptors
|
Kuo M.-L; Kuo S.-H; Cheng A.-L.; Yeh K.-H; Yeh P.-Y; Lien H.-C; YEN-SHEN LU; Yen-Shen Lu;Lien H.-C;Yeh P.-Y;Yeh K.-H;Kuo M.-L;Kuo S.-H;Cheng A.-L. |
| 臺大學術典藏 |
2020-05-25T06:52:07Z |
Glucocorticoid receptor expression in advanced non-small cell lung cancer: clinicopathological correlation and in vitro effect of glucocorticoid on cell growth and chemosensitivity
|
Yen-Shen Lu;Lien H.-C;Yeh P.-Y;Kuo S.-H;Chang W.-C;Kuo M.-L;Cheng A.-L.; YEN-SHEN LU; Lien H.-C; Yeh P.-Y; Kuo S.-H; Chang W.-C; Kuo M.-L; Cheng A.-L. |
| 臺大學術典藏 |
2020-05-25T06:52:06Z |
Dose variation and regimen modification of adjuvant chemotherapy in daily practice affect survival of stage I-II and operable stage III Taiwanese breast cancer patients
|
Huang C.-S.;Chen T.-Z;Lin C.-H;Yen-Shen Lu;You S.-L;Lien H.-C;Kuo S.-H; Kuo S.-H; Lien H.-C; You S.-L; YEN-SHEN LU; Lin C.-H; Chen T.-Z; Huang C.-S. |
| 臺大學術典藏 |
2020-05-25T06:52:05Z |
The CYP19 TTTA repeat polymorphism is related to the prognosis of premenopausal stage I-II and operable stage III breast cancers
|
Chang K.-J.;Yen-Shen Lu;Lin C.-H;Shen C.-Y;You S.-L;Yang S.-Y;Lien H.-C;Kuo S.-H;Huang C.-S; Huang C.-S; Kuo S.-H; Lien H.-C; Yang S.-Y; You S.-L; Shen C.-Y; Lin C.-H; YEN-SHEN LU; Chang K.-J. |
| 臺大學術典藏 |
2020-05-25T06:52:04Z |
Molecular subtypes of breast cancer emerging in young women in Taiwan: Evidence for more than just westernization as a reason for the disease in Asia
|
Cheng A.-L.;Chang K.-J;Kuo W.-H;Liu J.M;Lan C;Kuo S.-H;Shen Y.-C;Kuo K.-T;Lee W.-C;Huang C.-S;Yen-Shen Lu;Liau J.-Y;Lin C.-H; Lin C.-H; Liau J.-Y; YEN-SHEN LU; Huang C.-S; Lee W.-C; Kuo K.-T; Shen Y.-C; Kuo S.-H; Lan C; Liu J.M; Kuo W.-H; Chang K.-J; Cheng A.-L. |
| 臺大學術典藏 |
2020-05-25T06:52:01Z |
Combinations of mTORC1 inhibitor RAD001 with gemcitabine and paclitaxel for treating non-Hodgkin lymphoma
|
Chiang C.-T;Yeh P.-Y;Gao M;Chen C.-W;Yeh L.-C;Feng W.-C;Kuo S.-H;Hsu C.-H;Yen-Shen Lu;Cheng A.-L.; Chiang C.-T; Yeh P.-Y; Gao M; Chen C.-W; Yeh L.-C; Feng W.-C; Kuo S.-H; Hsu C.-H; YEN-SHEN LU; Cheng A.-L. |
| 臺大學術典藏 |
2020-05-25T06:52:00Z |
Lack of compensatory pAKT activation and eIF4E phosphorylation of lymphoma cells towards mTOR inhibitor, RAD001
|
Kuo S.-H;Hsu C.-H;Chen L.-T;Yen-Shen Lu;Lin C.-H;Yeh P.-Y;Jeng H.-J;Gao M;Yeh K.-H;Cheng A.-L.; Kuo S.-H; Hsu C.-H; Chen L.-T; YEN-SHEN LU; Lin C.-H; Yeh P.-Y; Jeng H.-J; Gao M; Yeh K.-H; Cheng A.-L. |
| 臺大學術典藏 |
2020-05-25T06:52:00Z |
Phase II study of docetaxel, capecitabine, and cisplatin as neoadjuvant chemotherapy for locally advanced breast cancer
|
Yen-Shen Lu;Chen D.-R;Tseng L.-M;Yeh D.-C;Chen S.-T;Hsieh C.-M;Wang H.-C;Yeh H.-T;Kuo S.-H;Huang C.-S.; YEN-SHEN LU; Chen D.-R; Tseng L.-M; Yeh D.-C; Chen S.-T; Hsieh C.-M; Wang H.-C; Yeh H.-T; Kuo S.-H; Huang C.-S. |
| 臺大學術典藏 |
2020-05-25T06:51:55Z |
CYP19 genetic polymorphism haplotype aasa is associated with a poor prognosis in premenopausal women with lymph node-negative, hormone receptor-positive breast cancer
|
Kuo S.-H;Yang S.-Y;Lien H.-C;Lo C;Lin C.-H;Yen-Shen Lu;Cheng A.-L;Chang K.-J;Huang C.-S.; Kuo S.-H; Yang S.-Y; Lien H.-C; Lo C; Lin C.-H; YEN-SHEN LU; Cheng A.-L; Chang K.-J; Huang C.-S. |
| 臺大學術典藏 |
2020-05-25T06:51:53Z |
High prevalence of the BIM deletion polymorphism in young female breast cancer in an East Asian country
|
Lin C.-H;Shen C.-Y;Lee J.-H;Huang C.-S;Yang C.-H;Kuo W.-H;Chang D.-Y;Hsiung C.-N;Kuo K.-T;Chen W.-W;Chen I.-C;Wu P.-F;Kuo S.-H;Chen C.-J;Yen-Shen Lu;Cheng A.-L.; Lin C.-H; Shen C.-Y; Lee J.-H; Huang C.-S; Yang C.-H; Kuo W.-H; Chang D.-Y; Hsiung C.-N; Kuo K.-T; Chen W.-W; Chen I.-C; Wu P.-F; Kuo S.-H; Chen C.-J; YEN-SHEN LU; Cheng A.-L. |
| 臺大學術典藏 |
2020-05-25T06:51:51Z |
Multiple gene sequencing for risk assessment in patients with early-onset or familial breast cancer
|
Lin P.-H;Kuo W.-H;Huang A.-C;Yen-Shen Lu;Lin C.-H;Kuo S.-H;Wang M.-Y;Liu C.-Y;Cheng F.T.-F;Yeh M.-H;Li H.-Y;Yang Y.-H;Hsu Y.-H;Fan S.-C;Li L.-Y;Yu S.-L;Chang K.-J;Chen P.-L;Ni Y.-H;Huang C.-S.; Lin P.-H; Kuo W.-H; Huang A.-C; YEN-SHEN LU; Lin C.-H; Kuo S.-H; Wang M.-Y; Liu C.-Y; Cheng F.T.-F; Yeh M.-H; Li H.-Y; Yang Y.-H; Hsu Y.-H; Fan S.-C; Li L.-Y; Yu S.-L; Chang K.-J; Chen P.-L; Ni Y.-H; Huang C.-S. |
| 臺大學術典藏 |
2020-05-25T06:51:49Z |
Locoregional Recurrence Risk for Postmastectomy Breast Cancer Patients With T1�V2 and One to Three Positive Lymph Nodes Receiving Modern Systemic Treatment Without Radiotherapy
|
Lai S.-F;Chen Y.-H;Kuo W.-H;Lien H.-C;Wang M.-Y;Yen-Shen Lu;Lo C;Kuo S.-H;Cheng A.-L;Huang C.-S.; Lai S.-F; Chen Y.-H; Kuo W.-H; Lien H.-C; Wang M.-Y; YEN-SHEN LU; Lo C; Kuo S.-H; Cheng A.-L; Huang C.-S. |
| 臺大學術典藏 |
2020-05-25T02:45:35Z |
The response, outcome and toxicity of aggressive palliative thoracic radiotherapy for metastatic non-small cell lung cancer patients with controlled extrathoracic diseases
|
Chiang Y; Yang J.C.-H; Feng-Ming Hsu; Chen Y.-H; Shih J.-Y; Lin Z.-Z; Lan K.-H; Cheng A.-L; Kuo S.-H. |
| 臺大學術典藏 |
2020-05-25T02:45:29Z |
Epidermal growth factor receptor mutation predicts favorable outcomes in non-small cell lung cancer patients with brain metastases treated with stereotactic radiosurgery
|
Yang W.-C;Xiao F;Shih J.-Y;Ho C.-C;Chen Y.-F;Tseng H.-M;Chen K.-Y;Liao W.-Y;Yu C.-J;Yang J.C.-H;Kuo S.-H;Cheng J.C.-H;Yang P.-C;Feng-Ming Hsu; Yang W.-C; Xiao F; Shih J.-Y; Ho C.-C; Chen Y.-F; Tseng H.-M; Chen K.-Y; Liao W.-Y; Yu C.-J; Yang J.C.-H; Kuo S.-H; Cheng J.C.-H; Yang P.-C; Feng-Ming Hsu |
| 臺大學術典藏 |
2020-05-18T08:39:07Z |
Effects of continuous intravenous epoprostenol therapy on advanced primary pulmonary hypertension in Taiwanese patients
|
Hsu H.-N.;Chen J.-S.;Kuo S.-H.;Chiang F.-T.;Ko W.-J.;Shuenn-Wen Kuo;Huang S.-C.;Lee Y.-C.; Hsu H.-N.; Chen J.-S.; Kuo S.-H.; Chiang F.-T.; Ko W.-J.; SHUENN-WEN KUO; Huang S.-C.; Lee Y.-C. |
| 臺大學術典藏 |
2020-05-14T06:59:51Z |
New Method to avoid End-effects on the Wake of Circular Cylinder at Low Reynolds Numbers
|
Wang, A.-B.; Wang, H.-C.; Kuo, S.-H.; AN-BANG WANG |
| 臺大學術典藏 |
2020-05-14T06:59:15Z |
New Method to avoid End-effects on the Wake of Circular Cylinder at Low Reynolds Numbers
|
Wang, A.-B.; Wang, H.-C.; Kuo, S.-H.; AN-BANG WANG |
| 臺大學術典藏 |
2020-05-14T06:59:14Z |
New Method to avoid End-effects on the Wake of Circular Cylinder at Low Reynolds Numbers
|
Kuo, S.-H.; Wang, A.-B.; AN-BANG WANG |
| 臺大學術典藏 |
2020-05-14T06:59:07Z |
A New Method to Generate Parallel Vortex Shedding from a Circular Cylinder in the Laminar Range with Less Side-effects
|
Wang, A.-B.; Kuo, S.-H.; Trávnícek, Z.; Hwang, Y.-S.; AN-BANG WANG |
| 臺大學術典藏 |
2020-04-28T07:25:37Z |
Phase II study of combination doxorubicin, interferon-α, and high-dose tamoxifen treatment for advanced hepatocellular carcinoma
|
CHIH-HUNG HSU; Wu C.-Y.; Cheng A.-L.; Lu Y.-S.;Hsu C.;Li C.-C.;Kuo S.-H.;Yeh K.-H.;Yang C.-H.;Chih-Hung Hsu;Wu C.-Y.;Cheng A.-L.; Lu Y.-S.; Hsu C.; Li C.-C.; Kuo S.-H.; Yeh K.-H.; Yang C.-H. |
| 臺大學術典藏 |
2020-04-28T07:25:35Z |
Phase II study of weekly paclitaxel and 24-hour infusion of high-dose 5-fluorouracil and leucovorin in the treatment of recurrent or metastatic gastric cancer
|
Yeh K.-H.;Lu Y.-S.;Chih-Hung Hsu;Lin J.-F.;Hsu C.;Kuo S.-H.;Li Jr. S.;Cheng A.-L.; Yeh K.-H.; Lu Y.-S.; CHIH-HUNG HSU; Lin J.-F.; Hsu C.; Kuo S.-H.; Li Jr. S.; Cheng A.-L. |
| 臺大學術典藏 |
2020-04-28T07:25:34Z |
A pathway for tumor necrosis factor-α-induced Bcl10 nuclear translocation: Bcl10 is up-regulated by NF-κB and phosphorylated by Akt1 and then complexes with Bcl3 to enter the nucleus
|
Pei Y.Y.;Kuo S.-H.;Yeh K.-H.;Chuang S.-E.;Chih-Hung Hsu;Wen C.C.;Lin H.-I.;Gao M.;Cheng A.-L.; Pei Y.Y.; Kuo S.-H.; Yeh K.-H.; Chuang S.-E.; CHIH-HUNG HSU; Wen C.C.; Lin H.-I.; Gao M.; Cheng A.-L. |
| 臺大學術典藏 |
2020-04-28T07:25:27Z |
Combinations of mTORC1 inhibitor RAD001 with gemcitabine and paclitaxel for treating non-Hodgkin lymphoma
|
Chiang C.-T.;Yeh P.-Y.;Gao M.;Chen C.-W.;Yeh L.-C.;Feng W.-C.;Kuo S.-H.;Chih-Hung Hsu;Lu Y.-S.;Cheng A.-L.; Chiang C.-T.; Yeh P.-Y.; Gao M.; Chen C.-W.; Yeh L.-C.; Feng W.-C.; Kuo S.-H.; CHIH-HUNG HSU; Lu Y.-S.; Cheng A.-L. |
